MGHbanner BulfinchBldg
MGH  Neurosurgical Service Home

Research at MGH Neurosurgical Service
Neurosurgery @ MGHspacer
Massachusetts General HospitalHarvard Medical School

MGH ShieldHvd Med Sch ShieldPartners Logo

Chiocca to Chair New Neurological Surgery Department

COLUMBUS, Ohio – The Ohio State University Medical Center will complement its strengths in neuroscience, neurology and cancer research by establishing a neurological surgery department and appointing a nationally recognized brain tumor specialist from Harvard University to chair the new department. Both actions were approved today (12/5) by the university’s Board of Trustees.

........more...

E.Antonio Chiocca, MD PhD
Chairman, Department of Neurological Surgery
Chiocca Lab Interests
Curriculum Vitae

Dardinger Family Professor of Oncologic Neurosurgery
Director of Neurosurgical Services
The Ohio State University Medical Center
James Cancer Hospital and Solove Research Institute
N-1017 Doan Hall
410 W, 10th Avenue
Columbus, OH 43210
Phone: 614-293-5444
Fax: 614-293-4281
Email: Chiocca-1@medctr.osu.edu

 

 

Molecular Neuro-Oncology Laboratory
E. Antonio Chiocca, M.D. Ph.D.
Investigator Photo

HomePage@Neurosurgery
Clinical Office PPD Information
Molecular Neuro-Oncology Laboratory
CNY 149-6005
Telephone: 617-726-4684
Fax: 617-726-5079
Email: chiocca@helix.mgh.harvard.edu

Chiocca Publications
Chiocca Pubs 2001
Chiocca Pubs 2000
Chiocca Pubs 1999

Major Research Interest - Gene Therapy:

Gene transfer technologies and applications to disorders of the central nervous system.

The capacity to transfer a particular gene into cells of the central nervous system is likely to provide a major technological advance in the treatment of disorders of the central nervous system (CNS). Vectors based on genetically modified viruses or on artificial constructs are becoming increasingly more efficient in their capacity to deliver and express a therapeutic gene in vivo into a selected target tissue. We have chosen experimental CNS tumors as a model to test vectors and anticancer genes for efficiency of expression and therapeutic effectiveness. Viral vectors based on herpes simplex virus (HSV) have been modified to shuttle in vivo into tumor cells genes that will activate pro-drugs, induce apoptosis, or stimulate a host immune response. We have also modified wild-type herpes virus to render its replication selective for tumor cells, by defining human tumor complementation groups that will allow for the growth of different mutants of the virus.

Currently active research areas include: 1) engineering more efficient "tumor-killing" vectors, 2) finding and testing novel prodrug/ gene therapy strategies, 3) using different classes of anticancer genes in combination, 4) correcting the genetic defects in brain tumor cells, 5) using vector technology to deliver therapeutic genes in animal models of peripheral nerve and spinal cord degeneration. Important questions related to brain tumor biology can also be investigated using gene transfer technologies.

Links

[Neurosurgical Service @ MGH]

Neurosurgery Clinical Units
bullet MGH Neurosurgical Service bullet Spine Tumor Center at MGH
bullet Brain Tumor Center at MGH bullet Research at MGH Neurosurgery
bullet Neuroscience Care Units at MGH bullet Residents at Neurosurgery
[Divider]
Disclaimer About Medical Information: The information and reference materials contained herein is intended solely for the information of the reader. It should not be used for treatment purposes, but rather for discussion with the patient's own physician. All visitors to this and associated sites from the Neurosurgical Service at MGH agree to read and abide by the the complete terms of legal agreement found at "disclaimer & legal agreement." © Copyright 2000
[Divider]
electronswebs
MGH  Neurosurgical Service Home
Research@NeurosurgeryVisitors must read the disclaimer - legal agreement.
© All Rights Reserved. Copyright © 2000 MGH Neurosurgical Service
MGH NeuroCare Info Systems
NeuroCare
(internal access only)
System Info Contact: WebServant or the PageServant or e-mail C.Owen
Last modified: Sunday, January 24, 2004
Referral@Neurosurgery.MassGeneral.org